COVID-19 : Coronavirus | The AstraZeneca vaccine is effective in people with diabetes

The vaccines against COVID-19 that have emerged in recent months are surrounded by doubts regarding their efficacy and safety in certain sectors of the population, something on which health authorities and various associations speak out to help the population. In this sense, the Spanish Society of Endocrinology and Nutrition (SEEN) assured on Tuesday in a statement that AstraZeneca’s vaccine “does not present any safety or efficacy concerns among patients with diabetes mellitus and / or other endocrinological and / or metabolic diseases.”

In the note, the company refers to the third update of the Vaccination Strategy of the Ministry of Health, published on February 9, in which it was recommended to use this vaccine “in people between 18 and 55 years old, except those with severe immunosuppression, uncontrolled cardiovascular disease and severe liver, kidney, metabolic / endocrine or neurological disease ”.

The company explains that this exclusion is not due to doubts regarding safety. In the statement it warns that clinical trials Assessed for AstraZeneca Vaccine Licensing included 39.3% of people with other associated diseasessuch as cardiovascular disease, respiratory disease, or diabetes. Besides, the efficacy in participants with one or more comorbidities was 58.3%, very similar to that observed in the general population.

Recommended to avoid a serious picture of COVID-19

From SEEN they recognize that “all medications, including vaccines, have side effects which, in the case of vaccines, are frequently mild such as fever, pain at the injection site, etc. or, less frequently, other more serious ones such as encephalitis, vasculitis, neuralgia, etc. ”. However, they assure that “The benefits of vaccination outweigh the risks.”

Therefore, society understands that people with diabetes “must be vaccinated with authorized vaccines against COVID-19, and so on. reduce your individual risk of serious illness associated with COVID-19”. “In the case of unstable or decompensated clinical situations, vaccination can be postponed until clinical recovery,” he says.